View Full Version : Novartis Inks Agreement For Immunogen's "TAP" ADC Technology
More... (http://www.news-medical.net/news/20131011/Novartis-Inks-Agreement-For-Immunogens-TAP-ADC-Technology.aspx)
'lizbeth
10-11-2013, 08:58 AM
Excellent news, especially since Novartis has so many breast cancer therapies in the pipeline. Hopefully this will lead to more ADC treatments. Perhaps this time, they can link a less toxic chemo with a MAB and increase both quantity and Quality of life.
vBulletin® v3.8.7, Copyright ©2000-2024, vBulletin Solutions, Inc.